Functional magnetic stimulation (FMS) is a method based on the use of a magnetic field to stimulate different parts of the body with the aim of their treatment or rehabilitation. As a noninvasive, relatively cheap and fast method without significant side effects, it is used for several decades for many parts of human body to reduce related pain or increase its functionality. In urology it is mainly indicated for pelvic floor rehabilitation to reduce problems with urination mostly in female patients, alone or more often in combination with different methods for pelvic floor rehabilitation. In this review we will present current role of FMS in patients with urinary incontinence after radical prostatectomy.
BackgroundSenhance Surgical System is a novel robotic platform used in University Hospital Centre Zagreb since February 2019. In this study, we present our 3‐year experience with this platform.Patients and MethodsData were prospectively collected for 200 patients who underwent extraperitoneal robotic radical prostatectomy (RRP) from May 2019 to March 2022.ResultsThe median age of the patients was 65 years, and the prostate‐specific antigen was 6.9 ng/mL. Clinically, most of the patients had T1c stage. The estimated blood loss was 250 mL, and there were 6 conversions to laparoscopic and 2 to open prostatectomy. There were 15 early postoperative complications, 11 Clavien‐Dindo classification grade I, 3 grade II and 1 grade IV. Functional outcomes in the first 150 patients: 140 patients (93.3%) had good urinary control. Thirteen patients underwent additional oncological treatment.ConclusionRRP performed with the Senhance robotic platform is a feasible and safe procedure with good initial results.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.